- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Blood advances. - 7, 22 (2023) , 7079-7083, ISSN: 2473-9537
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2023
- Urheber
- DOI
-
10.1182/bloodadvances.2022009096
- URN
-
urn:nbn:de:bsz:25-freidok-2412508
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schuster, Linda
- Syed, Afzal Pasha
- Tirier, Stephan Marius
- Steiger, Simon
- Seufert, Isabelle
- Becker, Heiko
- Duque Afonso, Jesús
- Ma, Tobias
- Ogawa, Seishi
- Mallm, Jan-Philipp
- Lübbert, Michael
- Rippe, Karsten
- Universität
Entstanden
- 2023
Ähnliche Objekte (12)
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
Molekulare Mechanismen der normalen myeloischen Differenzierung und ihrer Störung bei akuten myeloischen Leukämien
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
MDS und akute myeloische Leukämie : ein biologisches und therapeutisches Kontinuum
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Gemtuzumab ozogamicin in NPM1-mutated acute myeloid leukemia: early results from the prospective randomized AMLSG 09-09 Phase III Study
The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia
The clinical value of decitabine monotherapy in patients with acute myeloid leukemia
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
Molekulare Mechanismen der normalen myeloischen Differenzierung und ihrer Störung bei akuten myeloischen Leukämien
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
MDS und akute myeloische Leukämie : ein biologisches und therapeutisches Kontinuum
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Gemtuzumab ozogamicin in NPM1-mutated acute myeloid leukemia: early results from the prospective randomized AMLSG 09-09 Phase III Study
The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia
The clinical value of decitabine monotherapy in patients with acute myeloid leukemia
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
Molekulare Mechanismen der normalen myeloischen Differenzierung und ihrer Störung bei akuten myeloischen Leukämien
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
MDS und akute myeloische Leukämie : ein biologisches und therapeutisches Kontinuum
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Gemtuzumab ozogamicin in NPM1-mutated acute myeloid leukemia: early results from the prospective randomized AMLSG 09-09 Phase III Study
The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia
The clinical value of decitabine monotherapy in patients with acute myeloid leukemia
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)